Literature DB >> 9426747

The patient with an overactive bladder--symptoms and quality-of-life issues.

S Jackson1.   

Abstract

OBJECTIVES: Psychosocial adjustment to illness is an important as the status of the physical disease itself; focusing on this necessitates some measurement of abstract, subjective feelings of "quality of life" (QOL). Assessments of QOL are particularly important for conditions such as urinary incontinence (UI) that have little or no impact on mortality.
METHODS: This presentation describes the reasons for, and methods of, measuring lower urinary tract symptoms and disease impact. Validated instruments available for such measurements are reviewed, as are published studies that address the impact of UI (and urge incontinence in particular) on QOL. Potential applications for these new disease measures are discussed.
RESULTS: The bladder is an unreliable witness, and symptom assessment is diagnostically disappointing; cystometry is essential if a definitive diagnosis is required. However, objective tests take no account of the patient's perception of the problem. General health status questionnaires have been used to show that urge incontinence is associated with emotional problems, reduced social and recreational activity, and sexual dysfunction. Newly developed, condition-specific instruments have greater specificity and, hence, improved sensitivity for measuring incontinence and its impact. These instruments have the potential for monitoring disease progression and evaluating treatment outcome.
CONCLUSIONS: In a proportion of people with bladder overactivity, the disorder has a profound impact on the QOL. Methods of measuring this impact have been developed that may allow identification of this group of individuals while also improving the assessment of treatment efficacy. However, this science is in its infancy and these dimensions await further exploration.

Entities:  

Mesh:

Year:  1997        PMID: 9426747     DOI: 10.1016/s0090-4295(97)00580-3

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  20 in total

1.  Botulinum toxin A should not be first-line therapy for overactive bladder.

Authors:  Lesley K Carr
Journal:  Can Urol Assoc J       Date:  2011-06       Impact factor: 1.862

Review 2.  Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: systematic review.

Authors:  Peter Herbison; Jean Hay-Smith; Gaye Ellis; Kate Moore
Journal:  BMJ       Date:  2003-04-19

3.  Randomized controlled trial of foot reflexology for patients with symptomatic idiopathic detrusor overactivity.

Authors:  Ho-Leung Jimmy Mak; Willy Cecilia Cheon; To Wong; Yu Sun John Liu; Wai Mei Anny Tong
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-09-27

4.  Epidemiology of prolapse and incontinence questionnaire: validation of a new epidemiologic survey.

Authors:  Emily S Lukacz; Jean M Lawrence; J Galen Buckwalter; Raoul J Burchette; Charles W Nager; Karl M Luber
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2005-04-26

5.  The responsiveness of the Overactive Bladder Questionnaire (OAB-q).

Authors:  Karin S Coyne; Louis S Matza; Christine L Thompson
Journal:  Qual Life Res       Date:  2005-04       Impact factor: 4.147

Review 6.  Neurotoxin treatments for urinary incontinence in subjects with spinal cord injury or multiple sclerosis: a systematic review of effectiveness and adverse effects.

Authors:  Roderick MacDonald; Manoj Monga; Howard A Fink; Timothy J Wilt
Journal:  J Spinal Cord Med       Date:  2008       Impact factor: 1.985

7.  Oxybutynin extended-release: a review of its use in the management of overactive bladder.

Authors:  M Asif A Siddiqui; Caroline M Perry; Lesley J Scott
Journal:  Drugs       Date:  2004       Impact factor: 9.546

8.  Long-term safety of extended-release oxybutynin chloride in a community-dwelling population of participants with overactive bladder: a one-year study.

Authors:  Ananias Diokno; Peter Sand; Richard Labasky; Paul Sieber; Joseph Antoci; Gary Leach; Linda Atkinson; Detlef Albrecht
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

9.  The "bother" of urinary incontinence.

Authors:  Gerda Trutnovsky; Daniela Ulrich; Rodrigo Guzman Rojas; Kristy Mann; Thomas Aigmueller; Hans P Dietz
Journal:  Int Urogynecol J       Date:  2014-02-11       Impact factor: 2.894

10.  Sacral neuromodulation and refractory overactive bladder: an emerging tool for an old problem.

Authors:  Mai Ahmed Banakhar; Tariq Al-Shaiji; Magdy Hassouna
Journal:  Ther Adv Urol       Date:  2012-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.